139 related articles for article (PubMed ID: 33745912)
1. Optimal carbohydrate antigen 125 cutpoint for identifying low-risk patients after admission for acute heart failure.
Núñez J; Bayés-Genís A; Revuelta-López E; Miñana G; Santas E; Ter Maaten JM; de la Espriella R; Carratalá A; Lorenzo M; Palau P; Llàcer P; Valle A; Bodi V; Núñez E; Lupón J; Lang C; Ng LL; Metra M; Sanchis J; Voors AA
Rev Esp Cardiol (Engl Ed); 2022 Apr; 75(4):316-324. PubMed ID: 33745912
[TBL] [Abstract][Full Text] [Related]
2. Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis.
Núñez J; Bayés-Genís A; Revuelta-López E; Ter Maaten JM; Miñana G; Barallat J; Cserkóová A; Bodi V; Fernández-Cisnal A; Núñez E; Sanchis J; Lang C; Ng LL; Metra M; Voors AA
JACC Heart Fail; 2020 May; 8(5):386-397. PubMed ID: 32171764
[TBL] [Abstract][Full Text] [Related]
3. [Carbohydrate antigen 125 serial measurements after an admission for acute heart failure and risk of early readmission].
Miñana Escrivá G; Núñez J; Sanchis J; Bodi V; Núñez E; Chorro FJ; Llàcer A
Med Clin (Barc); 2012 Nov; 139(11):479-86. PubMed ID: 22093405
[TBL] [Abstract][Full Text] [Related]
4. Carbohydrate antigen 125 (CA125) as a prognostic marker in the elderly with acute heart failure and preserved ejection fraction.
Llàcer P; Núñez J; Manzano L; Cepeda Rodrigo JM; Salamanca Bautista P; Guzmán García M; Trullás Vila JC; Quirós López R; López Reboiro ML; Montero-Pérez-Barquero M;
Med Clin (Barc); 2022 Aug; 159(4):164-170. PubMed ID: 34895749
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of antigen carbohydrate 125 for planning the optimal length of stay in acute heart failure.
Lorenzo M; Palau P; Llàcer P; Domínguez E; Ventura B; Núñez G; Miñana G; Solsona J; Santas E; De La Espriella R; Bodí V; Núñez E; Sanchis J; Bayés-Genís A; Núñez J
Eur J Intern Med; 2021 Oct; 92():94-99. PubMed ID: 34130879
[TBL] [Abstract][Full Text] [Related]
6. Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study.
Núñez J; Llàcer P; Bertomeu-González V; Bosch MJ; Merlos P; García-Blas S; Montagud V; Bodí V; Bertomeu-Martínez V; Pedrosa V; Mendizábal A; Cordero A; Gallego J; Palau P; Miñana G; Santas E; Morell S; Llàcer A; Chorro FJ; Sanchis J; Fácila L;
JACC Heart Fail; 2016 Nov; 4(11):833-843. PubMed ID: 27522630
[TBL] [Abstract][Full Text] [Related]
7. Diuretic Strategies in Acute Heart Failure and Renal Dysfunction: Conventional vs Carbohydrate Antigen 125-guided Strategy. Clinical Trial Design.
García-Blas S; Bonanad C; Llàcer P; Ventura S; Núñez JM; Sánchez R; Chamorro C; Fácila L; de la Espriella R; Vaquer JM; Cordero A; Roqué M; Ortiz V; Racugno P; Bodí V; Valero E; Santas E; Moreno MDC; Miñana G; Carratalá A; Bondanza L; Payá A; Cardells I; Heredia R; Pellicer M; Valls G; Palau P; Bosch MJ; Raso R; Sánchez A; Bertomeu-González V; Bertomeu-Martínez V; Montagud-Balaguer V; Albiach-Montañana C; Pendás-Meneau J; Marcaida G; Cervantes-García S; San Antonio R; de Mingo E; Chorro FJ; Sanchis J; Núñez J;
Rev Esp Cardiol (Engl Ed); 2017 Dec; 70(12):1067-1073. PubMed ID: 28341415
[TBL] [Abstract][Full Text] [Related]
8. Antigen carbohydrate 125 and creatinine on admission for prediction of renal function response following loop diuretic administration in acute heart failure.
Núñez J; Llàcer P; Núñez E; Ventura S; Bonanad C; Bodí V; Miñana G; Santas E; Mascarell B; Fonarow GC; Chorro FJ; Sanchis J
Int J Cardiol; 2014 Jul; 174(3):516-23. PubMed ID: 24801083
[TBL] [Abstract][Full Text] [Related]
9. Differential Prognostic Value of Galectin-3 According to Carbohydrate Antigen 125 Levels in Transcatheter Aortic Valve Implantation.
Rheude T; Pellegrini C; Núñez J; Joner M; Trenkwalder T; Mayr NP; Holdenrieder S; Bodi V; Koenig W; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C; Husser O
Rev Esp Cardiol (Engl Ed); 2019 Nov; 72(11):907-915. PubMed ID: 30482731
[TBL] [Abstract][Full Text] [Related]
10. Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure.
Núñez J; Núñez E; Miñana G; Bodí V; Fonarow GC; Bertomeu-González V; Palau P; Merlos P; Ventura S; Chorro FJ; Llàcer P; Sanchis J
Eur J Heart Fail; 2012 Sep; 14(9):974-84. PubMed ID: 22700856
[TBL] [Abstract][Full Text] [Related]
11. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure.
Núñez J; Núñez E; Bayés-Genís A; Fonarow GC; Miñana G; Bodí V; Pascual-Figal D; Santas E; Garcia-Blas S; Chorro FJ; Rizopoulos D; Sanchis J
Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):685-696. PubMed ID: 27199489
[TBL] [Abstract][Full Text] [Related]
12. Prognostic effect of carbohydrate antigen 125-guided therapy in patients recently discharged for acute heart failure (CHANCE-HF). Study design.
Núñez J; Merlos P; Fácila L; Llàcer P; Bosch MJ; Bertomeu-Martínez V; García-Blas S; Montagud V; Pedrosa V; Mendizábal A; Cordero A; Miñana G; Sanchis J; Bertomeu-González V;
Rev Esp Cardiol (Engl Ed); 2015 Feb; 68(2):121-8. PubMed ID: 25623430
[TBL] [Abstract][Full Text] [Related]
13. Utility of plasma CA125 as a proxy of intra-abdominal pressure in patients with acute heart failure.
Rubio-Gracia J; Crespo-Aznarez S; De la Espriella R; Nuñez G; Sánchez-Marteles M; Garcés-Horna V; Yanguas-Barea N; Josa-Laorden C; Cobo-Marcos M; Giménez-López I; Pérez-Calvo JI; Nuñez J
Eur Heart J Acute Cardiovasc Care; 2022 Jun; 11(6):453-460. PubMed ID: 35512321
[TBL] [Abstract][Full Text] [Related]
14. Carbohydrate antigen 125 and risk of heart failure readmissions in patients with heart failure and preserved ejection fraction.
Miñana G; de la Espriella R; Palau P; Llácer P; Núñez E; Santas E; Valero E; Lorenzo M; Núñez G; Bodí V; Heredia R; Sanchis J; Bayés-Genís A; Chorro FJ; Núñez J
Sci Rep; 2022 Jan; 12(1):1344. PubMed ID: 35079082
[TBL] [Abstract][Full Text] [Related]
15. Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review.
Núñez J; de la Espriella R; Miñana G; Santas E; Llácer P; Núñez E; Palau P; Bodí V; Chorro FJ; Sanchis J; Lupón J; Bayés-Genís A
Eur J Heart Fail; 2021 Sep; 23(9):1445-1457. PubMed ID: 34241936
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of carbohydrate antigen 125 in stage D heart failure.
Zhang J; Li W; Xiao J; Hui J; Li Y
BMC Cardiovasc Disord; 2023 Feb; 23(1):108. PubMed ID: 36841766
[TBL] [Abstract][Full Text] [Related]
17. Early urinary sodium trajectory and risk of adverse outcomes in acute heart failure and renal dysfunction.
de la Espriella R; Núñez E; Llàcer P; García-Blas S; Ventura S; Núñez JM; Sánchez R; Fácila L; Vaquer JM; Bodí V; Santas E; Miñana G; Mollar A; Núñez G; Chorro FJ; Górriz JL; Sanchis J; Bayés-Genis A; Núñez J
Rev Esp Cardiol (Engl Ed); 2021 Jul; 74(7):616-623. PubMed ID: 32624444
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure.
Núñez J; Rabinovich GA; Sandino J; Mainar L; Palau P; Santas E; Villanueva MP; Núñez E; Bodí V; Chorro FJ; Miñana G; Sanchis J
PLoS One; 2015; 10(4):e0122360. PubMed ID: 25875367
[TBL] [Abstract][Full Text] [Related]
19. Carbohydrate antigen 125 predicts long-term mortality in African American patients with acute decompensated heart failure.
Mansour IN; Napan S; Tarek Alahdab M; Stamos TD
Congest Heart Fail; 2010; 16(1):15-20. PubMed ID: 20078623
[TBL] [Abstract][Full Text] [Related]
20. Antigen carbohydrate 125 and brain natriuretic peptide serial measurements for risk stratification following an episode of acute heart failure.
Núñez J; Núñez E; Sanchis J; Bodí V; Fonarow GC; Miñana G; Palau P; Bertomeu-González V; Carratalá A; Mainar L; Chorro FJ; Llàcer A
Int J Cardiol; 2012 Aug; 159(1):21-8. PubMed ID: 21367474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]